Patents by Inventor Eva E. Redei

Eva E. Redei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers predictive of predisposition to depression and response to treatment
    Patent number: 10544462
    Abstract: The present invention relates generally to the identification of subjects with a predisposition to recurrent depression, predicting a subject's responsiveness to therapy, and determining whether a subject has remitted from depression following therapy. In particular, provided herein are biomarkers, methods, and kits for such uses.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: January 28, 2020
    Assignee: NORTHWESTERN UNIVERSITY
    Inventor: Eva E. Redei
  • Compositions and methods for identifying depressive disorders
    Patent number: 10457991
    Abstract: Provided herein are compositions, kits, and methods for the identification of depressive disorders. In particular, provided herein are compositions, kits, and methods for the detection or diagnosis of major depressive disorder.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: October 29, 2019
    Assignee: Northwestern University
    Inventor: Eva E. Redei
  • Biomarkers for post-traumatic stress states
    Patent number: 10428384
    Abstract: The present invention relates generally to the detection or diagnosis of post-traumatic stress states in a subject, and provides methods, reagents, and kits useful for this purpose. Provided herein are biomarkers that are indicative of and/or diagnostic of post-traumatic stress states including PTSD.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: October 1, 2019
    Assignee: Northwestern University
    Inventor: Eva E. Redei
  • Biomarkers predictive of predisposition to depression and response to treatment
    Patent number: 10233501
    Abstract: The present invention relates generally to the identification of subjects with a predisposition to recurrent depression, predicting a subject's responsiveness to therapy, and determining whether a subject has remitted from depression following therapy. In particular, provided herein are biomarkers, methods, and kits for such uses.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: March 19, 2019
    Assignee: Northwestern University
    Inventor: Eva E. Redei
  • BIOMARKERS FOR POST-TRAUMATIC STRESS STATES
    Publication number: 20190048419
    Abstract: The present invention relates generally to the detection or diagnosis of post-traumatic stress states in a subject, and provides methods, reagents, and kits useful for this purpose. Provided herein are biomarkers that are indicative of and/or diagnostic of post-traumatic stress states including PTSD.
    Type: Application
    Filed: March 6, 2018
    Publication date: February 14, 2019
    Inventor: Eva E. Redei
  • Compositions and methods for identifying depressive disorders
    Patent number: 10093981
    Abstract: Provided herein are compositions, kits, and methods for the identification of depressive disorders. In particular, provided herein are compositions, kits, and methods for the detection or diagnosis of major depressive disorder.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: October 9, 2018
    Assignee: Northwestern University
    Inventor: Eva E. Redei
  • COMPOSITIONS AND METHODS FOR IDENTIFYING DEPRESSIVE DISORDERS
    Publication number: 20180073079
    Abstract: Provided herein are compositions, kits, and methods for the identification of depressive disorders. In particular, provided herein are compositions, kits, and methods for the detection or diagnosis of major depressive disorder.
    Type: Application
    Filed: October 6, 2017
    Publication date: March 15, 2018
    Inventor: Eva E. Redei
  • Biomarkers for post-traumatic stress states
    Patent number: 9909181
    Abstract: The present invention relates generally to the detection or diagnosis of post-traumatic stress states in a subject, and provides methods, reagents, and kits useful for this purpose. Provided herein are biomarkers that are indicative of and/or diagnostic of post-traumatic stress states including PTSD.
    Type: Grant
    Filed: December 12, 2014
    Date of Patent: March 6, 2018
    Assignee: NORTHWESTERN UNIVERSITY
    Inventor: Eva E. Redei
  • COMPOSITIONS AND METHODS FOR IDENTIFYING DEPRESSIVE DISORDERS
    Publication number: 20180057884
    Abstract: Provided herein are compositions, kits, and methods for the identification of depressive disorders. In particular, provided herein are compositions, kits, and methods for the detection or diagnosis of major depressive disorder.
    Type: Application
    Filed: October 6, 2017
    Publication date: March 1, 2018
    Inventor: Eva E. Redei
  • BIOMARKERS PREDICTIVE OF PREDISPOSITION TO DEPRESSION AND RESPONSE TO TREATMENT
    Publication number: 20180030538
    Abstract: The present invention relates generally to the identification of subjects with a predisposition to recurrent depression, predicting a subject's responsiveness to therapy, and determining whether a subject has remitted from depression following therapy. In particular, provided herein are biomarkers, methods, and kits for such uses.
    Type: Application
    Filed: October 6, 2017
    Publication date: February 1, 2018
    Inventor: Eva E. Redei
  • BIOMARKERS PREDICTIVE OF PREDISPOSITION TO DEPRESSION AND RESPONSE TO TREATMENT
    Publication number: 20180030539
    Abstract: The present invention relates generally to the identification of subjects with a predisposition to recurrent depression, predicting a subject's responsiveness to therapy, and determining whether a subject has remitted from depression following therapy. In particular, provided herein are biomarkers, methods, and kits for such uses.
    Type: Application
    Filed: October 6, 2017
    Publication date: February 1, 2018
    Inventor: Eva E. Redei
  • COMPOSITIONS AND METHODS FOR IDENTIFYING DEPRESSIVE DISORDERS
    Publication number: 20150225792
    Abstract: Provided herein are compositions, kits, and methods for the identification of depressive disorders. In particular, provided herein are compositions, kits, and methods for the detection or diagnosis of major depressive disorder.
    Type: Application
    Filed: January 16, 2015
    Publication date: August 13, 2015
    Inventor: Eva E. Redei
  • BIOMARKERS PREDICTIVE OF PREDISPOSITION TO DEPRESSION AND RESPONSE TO TREATMENT
    Publication number: 20150218639
    Abstract: The present invention relates generally to the identification of subjects with a predisposition to recurrent depression, predicting a subject's responsiveness to therapy, and determining whether a subject has remitted from depression following therapy. In particular, provided herein are biomarkers, methods, and kits for such uses.
    Type: Application
    Filed: January 16, 2015
    Publication date: August 6, 2015
    Inventor: Eva E. Redei
  • BIOMARKERS FOR POST-TRAUMATIC STRESS STATES
    Publication number: 20150167087
    Abstract: The present invention relates generally to the detection or diagnosis of post-traumatic stress states in a subject, and provides methods, reagents, and kits useful for this purpose. Provided herein are biomarkers that are indicative of and/or diagnostic of post-traumatic stress states including PTSD.
    Type: Application
    Filed: December 12, 2014
    Publication date: June 18, 2015
    Inventor: Eva E. Redei
  • Detection of maternal alcohol exposure
    Patent number: 8383352
    Abstract: The present invention provides methods, compositions, and systems for detecting in utero alcohol exposure by detecting expression level changes in certain biomarkers (e.g., in placental tissue). In certain embodiments, the biomarkers are selected from glucocorticoid receptor (GR), thyroid hormone receptor alpha (TR?), iodothyronine deiodinase III (Dio3) and G-protein ?-subunit (Gs?).
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: February 26, 2013
    Assignee: Northwestern University
    Inventors: Eva E. Redei, Pradeep K. Shukla, Laura J. Sittig
  • DETECTION OF MATERNAL ALCOHOL EXPOSURE
    Publication number: 20100311067
    Abstract: The present invention provides methods, compositions, and systems for detecting in utero alcohol exposure by detecting expression level changes in certain biomarkers (e.g., in placental tissue). In certain embodiments, the biomarkers are selected from glucocorticoid receptor (GR), thyroid hormone receptor alpha (TR?), iodothyronine deiodinase III (Dio3) and G-protein ?-subunit (Gs?).
    Type: Application
    Filed: June 7, 2010
    Publication date: December 9, 2010
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Eva E. REDEI, Pradeep K. SHUKLA, Laura J. Sittig